## 

## 



## 

## 

## 

|`REGISTEREDADDRESS`|`BANKERS`|`AUDITOR`|
|---|---|---|
|`TheGables`|`BarclaysBankPLC`|`CroweU.K.LLP`|
|`5TudorRoad`|`Leicester`|`55LudgateHill`|
|`Pinner`|`LE872BB`|`London`|
|`Middlesex`||`EC4M7JW`|
|`HAS3RZ`||`UK`|



## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 





## 

## 

## 

## 

## 



## 

## 

## 

## 


## 




## 

||`Unrestricted`|`Endowment`|`Total`|`Unrestricted`|`Endowment`|`Total`|
|---|---|---|---|---|---|---|
||`Fund`|`Fund`|`Fund`|`Fund`|`Fund`|`Fund`|
||`2025`|`2025`|`2025`|`2024`|`2024`|`2024`|
||`£`|`£`|`£`|`£`|`£`|`£`|
|`Incomefrom:`|||||||
|`Investments`|`113,015`|`-`|`113,015`|`101,424`|`-`|`101,424`|
|`Expenditureon:`|||||||
|`Charitableactivities`|`98,478`|`-`|`98,478`|`98,718`|`-`|`98,718`|
|`(Note3)`|||||||
|`Net(losses)/gains`|||||||
|`oninvestments(Note`|||||||
|`4)`|`-`|`(25,009)`|`(25,009)`|`-`|`192,390`|`192,390`|
|`NetIncome/`|||||||
|`(Expenditure)`|`14,537`|`(25,009)`|`(10,472)`|`2,706`|`192,390`|`195,096`|
|`TotalFundsbrought`|||||||
|`forwardat1 April`|||||||
|`2024`|`144,239`|`2,621,563`|`2,765,802`|`141,533`|`2,429,173`|`2,570,706`|
|`TotalFundscarried`|||||||
|`forwardat31March`|||||||
|`2025`|`158,776`|`2,596,554`|`2,755,330`|`144,239`|`2,621,563`|`2,765,802`|





## 

||||`2025`||`2024`|
|---|---|---|---|---|---|
||`Note`|`£`|`£`|`£`|`£`|
|`FIXEDASSETS`||||||
|`Investments`|`4`||`2,596,554`||`2,621,563`|
|`CURRENTASSETS`||||||
|`Accruedincome`<br>`BankBalances`|`5`|`6,915`<br>`351,546`||`6,655`<br>`275,589`||
|`CREDITORS:AMOUNTSFALLING`|<br>`6`||`358,461`||`282,244`|
|`DUEWITHINONEYEAR`|||`(199,685)`||`(138,005)`|
|`NETASSETS`|||`2,755,330`||`2,765,802`|
|`Representing:`||||||
|`FUNDS`||||||
|`EndowmentFunds`|`2,9,10`||`2,596,554`||`2,621,563`|
|`UnrestrictedFunds`|`9,10`||`158,776`||`144,239`|
||||`2,755,330`||`2,765,802`|






## 

## 



## 

|`ANALYSISOFEXPENDITURE`|`Direct`|`Support`||`Total`|`Total`|
|---|---|---|---|---|---|
||`costs`|`costs`||`2025`|`2024`|
||`£`|`£`||`£`|`£`|
|`GrantstoNorthLondonCollegiateSchool`||||||
|`MusicScholarshipawards`|`-`||`-`|`-`|`46,000`|
|`AdvancementofEducationinScience`||||||
|`-ScienceEquipment-Physics`<br>`-ScienceLaboratories`|`6,540`<br>`33,000`||`-`<br>`-`|`6,540`<br>`33,000`|`=`<br>`33,000`|
|`AnnualSciencePrize`|`150`||`-`|`150`|`225`|
|`Othercharitableandeducationalpurposes`<br>`-SupplementarygrantstoBursaryHolders`<br>`-Choralandinstrumentalmasterclasses`<br>`-Extendedessaysandsciencedisplays`|`-`<br>`-`<br>`-`||`-`<br>`-`<br>`-`|`-`<br>`-`<br>`-`|`3,000`<br>`10,500`<br>`8,500`|
|`MusicTechnologySuite`|`70,000`||`-`|`70,000`|`-`|
|`UnusedamountsreturnedtoTrust`|`(15,190)`||`-`|`(15,190)`|`(6,287)`|
|`Governance`<br>`Auditfee`<br>`Sundries`|`-`|`3,960`<br>`18`|<br>|`3,960`<br>`18`|`3,780`<br>`-`|
|`Total`|`94,500`|`3,978`||`98,478`|`98,718`|
|`INVESTMENTS`||||||
|`InvestmentsoftheTrustcomprise:`||||`Market`|`value`|
|||||`2025`|`2024`|
|||||`£`|`£`|
|`UKlistedequities-Glaxo`||||`257,312`|`300,714`|
|`-Haleon`||||`86,020`|`73,282`|
|`M&GEquitiesFundforCharities`||||`850,248`|`815,405`|
|`BlackRockCharitiesEquitiesFund`||||`105,286`|`101,239`|
|`COIFCharitiesInvestmentFund`||||`631,346`|`662,200`|
|`BlackRockGrowthandIncomeFund`||||`283,109`|`294367`|
|`COIFCharities FixedInterestFund`||||`260,856`|`254,260`|
|`NewtonGrowthandIncomeFund`||||`122,377`|`120,096`|
|||||`2,596,554`|`2,621,563`|
|`Movementsduringtheyearwere:`||||||
|||||`Market`|`Market`|
|||||`Value2025`|`Value2024`|
|||||`£`|`£`|
|`Broughtforwardat1 April2024`||||`2,621,563`|`2,429,173`|
|`Unrealised(losses)/gains`||||`(25,009)`|`192,390`|
|`Carriedforwardat31March2025`||||`2,596,554`|`2,621,563`|





## 

||`ACCRUEDINCOME`|`2025`|`2024`|
|---|---|---|---|
|||`£`|`E`|
||`GlaxoSmithKlineincome`|`2,800`|`2,800`|
||`NewtonGrowthandIncomeFund`|`500`|`500`|
||`BlackRock-InvestmentFunds`|`3,615`|`3,355`|
|||`6,915`|`6,655`|
|`6`|`CREDITORS`|`2025`|`2024`|
|||`£`|`£`|
||`NorthLondonCollegiateSchool`|`195,725`|`134,225`|
||`Othercreditors`|`3,960`|`3,780`|
|||`199,685`|`138,005`|



## 

||||`2025`|`2024`|
|---|---|---|---|---|
||||`£`|`£`|
|`Amountspaidtoauditors`|||||
|`Auditservices— CroweU.K.LLP`|||`3,960`|`3,780`|
||||`3,960`|`3,780`|
|`ANALYSISOFNETASSETSBETWEENFUNDS`|||||
|`Fundbalancesat31March2025arerepresentedby:`|||||
||||`Total`|`Total`|
||`Unrestricted`|`Endowment`|`Funds`|`Funds`|
||`Funds`|`Funds`|`2025`|`2024`|
||`£`|`£`|`£`|`£`|
|`FixedAssetsandInvestments`|`-`|`2,596,554`|`2,596,554`|`2,621,563`|
|`CurrentAssets`|`358,461`|`-`|`358,461`|`282,244`|
|`Creditors`|||||
|`Amountsfallingduewithinoneyear`|`(199,685)`|`-`|`(199,685)`|`(138,005)`|
|`Carriedforwardat31March2025`|`158,776`|`2,596,554`|`2,755,330`|`2,765,802`|





## 

## 

||`At1 April`|||`(Unrealised`|`At31March`|
|---|---|---|---|---|---|
||`2024`|`Income`|`Expenditure`|`loss)`|`2025`|
||`£`|`£`|`£`|`£`|`£`|
|`EndowmentFunds`|`2,621,563`|`-`|`-`|`(25,009)`|`2,596,554`|
|`UnrestrictedFunds`|`144,239`|`113,015`|`(98,478)`|`-`|`158,776`|
|`Total`|`2,765,802`|`113,015`|`(98,478)`|`(25,009)`|`2,755,330`|
|`COMPARATIVENOTES-ANALYSISOFNETASSETS`|||`BETWEENFUNDS`|||
|`Fundbalancesat31March`|`2024arerepresentedby:`|||||
|||||`Total`|`Total`|
|||`Unrestricted`|`Endowment`|`Funds`|`Funds`|
|||`Funds`|`Funds`|`2024`|`2023`|
|||`£`|`£`|`£`|`£`|
|`FixedAssetsandInvestments`||`-`|`2,621,563`|`2,621,563`|`2,429,173`|
|`CurrentAssets`||`282,244`|`-`|`282,244`|`312,020`|
|`Creditors`||||||
|`Amountsfallingduewithin`|`oneyear`|`(138,005)`|<br>`-`|`(138,005)`|`(170,487)`|
|`Carriedforwardat31March`|`2024`|`144,239`|`2,621,563`|`2,/65,802`|`2,570,706`|
|`COMPARATIVENOTES-STATEMENT`||`OFFUNDS`||||
||`At1 April`||||`At31March`|
||`2023`|`Income.`|`Expenditure`|`Unrealisedgain`|`2024`|
||`£`|`£`|`£`|`£`|`£`|
|`EndowmentFunds`|`2,429,173`|`-`|`-`|`192,390`|`2,621,563`|
|`UnrestrictedFunds`|`141,533`|`101,424`|`(98,718)`||`144,239`|
|`Total`|`2,570,706`|`101,424`|`(98,718)`|`192,390`|`2,765,802`|



## 



## 

## 

##